Lilly is building a multi-engine growth machine: Alzheimer's Treatment Kisunla (Donanemab) - FDA-approved for early Alzheimer's, first proven to slow cognitive decline Represents a breakthrough in neurodegenerative disease treatment Oncology & Immunology Verzenio (breast cancer): $1.47B in Q3 2025 (+7% YoY) Jaypirca and Omvoh expanding in oncology and autoimmune markets Radiopharmaceutical investments through Point Biopharma ($1.4B acquisition) and Aktis Oncology partnership Pipeline Depth 40+ programs in Phase 2/3 across neuroscience, immunology, and cardiology Recent acquisitions: Scorpion Therapeutics, SiteOne Therapeutics, Adverum Biotechnologies Lilly isn't a one-trick pony
[DOI] [PubMed] [Google Scholar] 123.Shi M-H, Wu Y, Li L, Cai Y-F, Liu M, Gao X-H, et al
Virus-induced inflammation is thought to contribute to neurodegeneration [50], as is multiple hit damage [51]
Why Copper Peptides Are Especially Valuable for Men Men face a specific set of skin and hair concerns that copper peptides are uniquely well-positioned to address: Higher rates of androgenetic alopecia: Male pattern baldness affects approximately 50% of men by age 50 and up to 80% by age 70 dramatically higher rates than in women
You feel satisfied sooner, stay fuller longer, and naturally eat less without forcing yourself to skip meals
The penile arteries are among the smallest in the body, typically 1 to 2 millimeters in diameter